Moderna, Inc. (MRNA)
154.19
+13.85
(+9.87%)
USD |
NASDAQ |
Sep 01, 16:00
153.20
-0.99
(-0.64%)
After-Hours: 16:19
Moderna Cash from Operations (Annual) : -1.873B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.873B |
| December 31, 2024 | -3.004B |
| December 31, 2023 | -3.118B |
| December 31, 2022 | 4.981B |
| December 31, 2021 | 13.62B |
| Date | Value |
|---|---|
| December 31, 2020 | 2.027B |
| December 31, 2019 | -458.00M |
| December 31, 2018 | -330.86M |
| December 31, 2017 | -331.48M |
| December 31, 2016 | 66.73M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | -222.54M |
| BioNTech SE | 514.63M |
| Kailera Therapeutics, Inc. | -120.21M |
| Twist Bioscience Corp. | -47.63M |
| Revolution Medicines, Inc. | -897.74M |